Recent Citation:
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.  Journal of Immunological Methods, Feb. 2021. 

About SARS-CoV-2 Spike S1 Protein

The Spike (S) glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the major surface protein responsible for viral attachment, host-cell recognition, and initiation of infection. The spike protein exists as a trimer on the viral surface and is composed of two functional subunits, S1 and S2. The S1 subunit contains the receptor-binding domain (RBD), which specifically recognizes and binds the human angiotensin-converting enzyme 2 (ACE2) receptor, representing the critical first step in viral entry. Because the S1 subunit mediates receptor recognition and contains major neutralizing epitopes, it has become one of the most important targets for vaccine development, neutralizing antibody discovery, diagnostic assay development, and antiviral therapeutic research.

The SARS-CoV-2 Spike S1 protein is highly immunogenic and serves as a principal target of humoral immune responses generated during natural infection and vaccination. Antibodies directed against the S1 subunit, particularly within the receptor-binding domain, can block ACE2 binding and inhibit viral entry into susceptible host cells. Consequently, the S1 protein has been widely utilized in studies of viral pathogenesis, antibody characterization, vaccine evaluation, immune monitoring, and serological assay development.

eEnzyme's recombinant SARS-CoV-2 Spike S1 Protein provides a valuable research reagent for investigations of receptor binding, viral entry mechanisms, vaccine development, neutralizing antibody screening, structural biology, and immunological assay development. Researchers can utilize this recombinant antigen to characterize antibody responses, evaluate vaccine candidates, investigate ACE2 interactions, and support the development of next-generation antiviral therapeutics and diagnostic technologies.

Applications of SARS-CoV-2 Spike S1 Protein

• Neutralizing antibody discovery and characterization
• COVID-19 vaccine development and evaluation
• ACE2 receptor-binding studies
• Viral attachment and entry investigations
• Structural biology and epitope mapping
• Serological assay development
• ELISA, Western blot, and immunological assays
• Antiviral therapeutic research

Biological Significance of the Spike S1 Subunit

The S1 subunit of the SARS-CoV-2 spike protein is responsible for host-cell receptor recognition and determines viral tropism and infectivity. Through its receptor-binding domain, S1 interacts directly with ACE2 expressed on susceptible host cells, initiating the viral entry process. Following receptor engagement, structural changes within the spike protein allow activation of the S2 fusion machinery and subsequent membrane fusion. Because S1 contains the dominant neutralizing epitopes targeted by protective antibodies and serves as a key antigen in many vaccine platforms, it remains one of the most extensively studied viral proteins in coronavirus research. Studies of the S1 subunit continue to provide critical insights into viral evolution, immune escape mechanisms, vaccine design, and therapeutic antibody development.